Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 1mg dose of Wegovy isn't a standard pen in the UK titration schedule — it sits between the licensed steps of 0.5mg and 1.7mg, so if you're searching for a '1mg pen price', it's worth pausing. UK private Wegovy pricing is set per pen by each provider, and any legitimate figure includes a prescription issued by a registered prescriber following clinical assessment. Prices across the private market vary by dose and provider; context matters more than the headline number. Wegovy is a prescription-only medicine, which means a clinician decides whether it's right for you — no listing price changes that requirement.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people searching for a specific Wegovy pen price assume that a lower-strength pen automatically means a lower overall cost. The reality is more layered. Wegovy's licensed UK titration runs from 0.25mg through 0.5mg, then 1.7mg and 2.4mg, with 7.2mg now also approved by the MHRA as a higher maintenance option for eligible adults. A '1mg' step doesn't appear in the standard schedule; the full picture on 1mg Wegovy pricing in the UK explains why that dose designation can be confusing when it appears on listings.
The more significant point is this: the price of a single pen is rarely the cost of treatment. Most people spend several months at each dose level before their prescriber reviews whether to titrate upward. If you want to see how that plays out at one specific step, wegovy 1mg prices broken down by what's typically included show how quickly the full-course figure diverges from the headline number. That's the number worth calculating.
NICE's appraisal of semaglutide for weight management, published as TA875, gives useful context on how the medicine is evaluated clinically, it's written for commissioners, but the eligibility criteria it sets out are a reasonable guide to what legitimate prescribers assess.
Browse enough private weight-loss clinic websites and a pattern emerges. The number in the largest font is typically the pen price alone. Scroll further and you may find a consultation fee charged separately, a prescription charge on top, a delivery fee per order, and (less obviously) no clear route to clinical support if something feels wrong between doses.
For a medicine that requires titration decisions, ongoing clinical review and a way to escalate concerns quickly, aftercare isn't optional. It's part of the service. Looking at what a Wegovy pen price actually covers across different UK providers makes it easier to compare like with like, rather than the pen cost in isolation.
A quick check you can do right now: look up any online pharmacy on the GPhC register. If a provider isn't registered, walk away. If they are, their registration number tells you they're operating under UK pharmacy law, that's a meaningful baseline, though it doesn't guarantee what's included in the price.
At nume, one price covers the consultation, the prescription, the medicine, and next-working-day delivery. There are no separate fees stacked underneath. Aftercare is available seven days a week; every repeat order goes through a fresh clinical review before anything is dispensed. We don't run discount codes or promotional offers for prescription medicines, and we don't think that's a loss. A GPhC-registered pharmacy with its own prescribers, operating under UK regulatory oversight, has costs that reflect what genuine clinical safety infrastructure actually takes to run.
We're aware that a price comparison will often show cheaper options. That's a deliberate choice on our part. The question isn't which provider lists the lowest number, it's which provider has the clinical rigour to back up what they're dispensing. Our clinical team reviews every consultation personally. If you want to understand what's included at each dose level, the cost breakdown at higher maintenance doses gives a useful comparison point, and wegovy pen prices across the full titration range show how those figures sit relative to one another.
The MHRA has been direct about the risks of sourcing GLP-1 medicines through unverified sellers. Counterfeit weight-loss pens have been seized across the UK in significant numbers; some contained insulin rather than semaglutide, with serious consequences for patients who had no idea what they were injecting. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk exists partly to capture exactly these reports.
A price that seems unusually low for a Wegovy pen (especially from a seller offering it without clinical assessment) is a reason for caution, not celebration. Legitimate supply means sourcing through the licensed UK chain, with a prescription issued after a proper clinical review. The treatment options available through a regulated UK pharmacy are a very different proposition from what circulates through unverified online channels.
For the actual current pricing at nume, the free consultation page sets out what's included. No hidden layers. Start there.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.